A nuclear technologist ordered and administered 25 mCi of
Technetium 99m-methyl diphosphonate (99mTc MDP) to a patient undergoing a gastric emptying scan. 99mTc MDP is a radioisotope used especially for bone scans. The formulation that should have been ordered and administered is 500 microCuries of Tc 99m
Sulfur colloid, which is generally used for the gastric study.
Both the patient and prescribing physician have been notified. The dose received by the patient is under evaluation at this time. No harmful effects to the patient are expected.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.
- * * RETRACTION FROM DAVID WISHKO TO DANIEL MILLS AT 1323 EDT ON 08/02/2016 * * *
Upon further analysis, the dose administered to the patient did not exceed the limits listed in 10 CFR 35.3045, and therefore this event is not reportable.
Notified R1DO (Kennedy) and
NMSS (email).